Nurse Practitioner, Adult Health · Miamisburg, OH
NPI
1033117932
Since 2005
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
415 Byers Rd, Suite 300
Miamisburg, OH, 45342
Phone (937) 866-2494
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
295 services
Medicare patients, 2024
71
Average age 74
Drug cost, 2024
$1.6M
3,385 prescriptions
Company payments, 2025
$62.93
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sandra L Kimball was code 99214 (office e&m - established), 152 times for 70 patients. In total Sandra L Kimball billed 295 services in 8 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 152 | 70 | $67.21 | $10K |
| 83036 Blood Count | Office | 135 | 65 | $9.28 | $1,253 |
By year: 2022 $17K for 503 services; 2023 $13K for 332 services; 2024 $12K for 295 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 135 | 65 | $9.28 | $1,253 |
Medicare prescription drug claims, 2024
In 2024, the drug Sandra L Kimball prescribed most often to Medicare patients was Toujeo Solostar (Insulin Glargine,hum.Rec.Anlog), with 394 prescriptions and refills. In total Sandra L Kimball wrote 3,385 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 394 | 579 | 98 | $284K |
| Glimepiride Generic | 346 | 923 | 119 | $2,473 |
| Ozempic Semaglutide | 219 | 269 | 44 | $249K |
| Metformin Hcl Er Metformin Hcl | 187 | 488 | 64 | $1,196 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 153 | 175 | 35 | $33K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 149 | 207 | 35 | $27K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 110 | 266 | 46 | $9,349 |
| Jardiance Empagliflozin | 106 | 164 | 26 | $97K |
| Mounjaro Tirzepatide | 106 | 117 | 16 | $125K |
| Trulicity Dulaglutide | 91 | 140 | 22 | $139K |
| Novolog Flexpen Insulin Aspart | 85 | 145 | 24 | $22K |
| Pioglitazone Hcl Generic | 84 | 227 | 22 | $634 |
| Metformin Hcl Generic | 74 | 195 | 25 | $528 |
| Humalog Kwikpen U-100 Insulin Lispro | 72 | 113 | 21 | $21K |
| Farxiga Dapagliflozin Propanediol | 67 | 125 | 14 | $68K |
Brand drugs: 1,996 claims; generic drugs: 945 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sandra L Kimball $62.93 ($62.93 in general payments such as food, travel and fees) from 2 companies. The largest payer was Mannkind Corporation with $42.5.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.